CuraRad-ICH

by CuraCloud  · Based in China → — AI-powered Stroke Care
Emergency Medicine Neurology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

CuraRad-ICH is an AI-powered software workflow tool developed by CuraCloud. It is designed to aid in prioritizing the clinical assessment of adult non-contrast head CT cases that show features suggestive of acute intracranial hemorrhage (ICH). The software utilizes deep learning algorithms to analyze CT images and identify suspected ICH findings, making case-level output available to a PACS/workstation for worklist prioritization or triage. Its primary goal is to reduce radiologist turnaround time for suspected ICH cases, thereby potentially speeding up emergency care decisions for this urgent condition. The deep learning model was trained and validated using diverse data sources from numerous imaging facilities across the U.S. and China.

Note: According to Tracxn, CuraCloud (based in Seattle, founded 2016) is a deadpooled company as of April 2026. This information reflects the tool’s capabilities and regulatory status when the company was active.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Deep learning algorithms for ICH detection
  • Computer-aided triage and notification
  • Worklist prioritization for PACS/workstations
  • Analysis of adult non-contrast head CT scans
  • Reduces radiologist turnaround time
  • Seamless integration with PACS/VNA and worklist applications
  • Average processing time of approximately 20-43 seconds per case

Use Cases

  • Prioritizing acute intracranial hemorrhage cases in emergency settings
  • Expediting diagnosis of ICH on head NCCT
  • Improving radiologist performance in detecting ICH
  • Reducing misdiagnosis of ICH

What Physicians Need to Know

Brain MRI/CT Analysis
CuraRad-ICH is a computer-aided triage and notification application designed for detecting intracranial hemorrhage (ICH) on non-contrast head CT scans. It uses deep-learning algorithms to analyze cases and output findings to a PACS workstation. The software was trained and validated using CT images from over 300 imaging facilities across the U.S..
Triage Prioritization Speed
The core AI engine of CuraRad-ICH processes each case in an average of about 20 seconds. This rapid analysis helps in prioritizing the clinical assessment of adult noncontrast head CT cases suggestive of acute ICH. CuraRad-ICH has a reported processing time of 43 seconds for ICH detection. AI-enabled SaMDs like CuraRad-ICH play a critical role in expediting the triaging process by rapidly analyzing patient data and identifying critical cases that necessitate immediate attention.
Mobile Notification System
AI-enabled devices can inform clinicians for prioritization purposes through various methods, including mobile applications. The prompt notification of critical findings by AI algorithms can significantly impact clinical decision-making, treatment planning, and patient outcomes.
Physician Tip

CuraRad-ICH is intended to aid in prioritizing the clinical assessment of adult noncontrast head CT cases with features suggestive of acute intracranial hemorrhage. It is a software workflow tool that operates in parallel to standard-of-care workflow and provides PACS-agnostic integration. The automated detection and rapid notification can help expedite the triage process for suspected ICH cases, allowing for faster intervention and potentially improved patient outcomes. Physicians should integrate the AI's findings with their overall clinical assessment, as the software is designed to assist, not replace, clinical judgment.

CuraRad-ICH is designed for integration with PACS workstations for worklist prioritization or triage purposes. It offers PACS-agnostic integration and operates in parallel with existing workflows. The software outputs its findings on a case level to a PACS workstation.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Unknown
DeploymentCloud-based
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

CuraRad-ICH is an AI-powered software developed by CuraCloud that assists in the detection and prioritization of intracranial hemorrhage (ICH) on head CT scans. It uses deep-learning algorithms to analyze non-contrast head CT cases and flag those suggestive of acute ICH, aiming to expedite clinical assessment and improve patient outcomes. The software received FDA 510(k) clearance in April 2020.

Overall: Positive

Strengths

  • Aids in prioritizing clinical assessment of adult non-contrast head CT cases with suspected acute ICH.
  • Employs deep-learning algorithms for analysis.
  • Outputs findings to PACS workstations for worklist prioritization or triage.
  • Trained and validated using CT images from over 300 imaging facilities across the U.S.
  • Fast processing time, averaging about 20 seconds per case.
  • Potential to enhance diagnostic accuracy and expedite treatment for stroke patients.

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: AuntMinnie.com, NIH.gov, Innolitics.com, AIHealthcareNow.com, researcher.life, healthaidb.com, semanticscholar.org, researchgate.net, preprints.org

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CuraRad-ICH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

auntminnie.com
CuraCloud gets FDA nod for ICH triage software
CuraCloud received U.S. FDA 510(k) clearance for CuraRad-ICH, a computer-aided triage and notification application for detecting intracranial hemorrhage (ICH) on head CT scans. The software uses deep-learning algorithms to analyze cases and outputs findings to a PACS workstation for worklist prioritization.
2020-04
biomedicalimaging.org
CuraCloud Corporation Announces FDA 510(k) Clearance for CuraRad-ICH
CuraCloud Corporation announced on April 13, 2020, that its computer-aided triage and notification system, CuraRad-ICH, for the early recognition of intracranial hemorrhage (ICH) from head CT scans, received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
2020-04
fda.gov
510(k) Premarket Notification K192167
The FDA granted 510(k) clearance for CuraRad-ICH on April 13, 2020. This regulatory document details the device's intended use as a software workflow tool to aid in prioritizing the clinical assessment of adult non-contrast head CT cases with features suggestive of acute intracranial hemorrhage.
2020-04
nih.gov
AI/ML-based medical devices in the USA
This article mentions CuraRad-ICH as one of the 45 FDA-approved AI/ML-based medical devices, with its 510(k) clearance in April 2020 for triage and notification of intracranial hemorrhage. It also notes a change in its algorithm in 2020, increasing sensitivity and specificity.
2022-10
nih.gov
AI/ML-enabled technologies for stroke: a systematic review of FDA-approved devices and their clinical performance
CuraRad-ICH by CuraCloud is listed as an FDA-approved device for ICH detection in non-contrast CT scans, with its 510(k) clearance in April 2020. The article discusses the growing regulatory confidence in imaging AI for acute stroke triage and quantification.
2023-05
encyclopedia.pub
Artificial Intelligence in Translational Medicine
CuraRad-ICH (CuraCloud Corp., Seattle, WA, USA) is listed as a deep learning tool used for triaging suspected intracranial hemorrhage, with its K192167 regulatory clearance in April 2020. This publication highlights the role of AI in advancing human health through translational research.
2021-12
aihealthcarenow.com
FDA-Cleared AI
CuraRad-ICH from Curacloud Corp. is listed among FDA-cleared AI devices, with its clearance date noted as April 13, 2020, and K192167 as its submission number.
2026-10
innolitics.com
FDA 510(k) Clearances for AI/ML-based SaMD
CuraRad-ICH by CuraCloud Corp. is mentioned in a discussion about FDA 510(k) clearances for AI/ML-based Software as a Medical Device (SaMD). The summary describes the software as integrating with third-party systems to receive requests and return findings, explicitly stating "Non-Diagnostic Preview: No".
2025-05

Videos

Product demos, reviews, and walkthroughs for CuraRad-ICH.

Loading videos...

View all on YouTube

Frequently Asked Questions

CuraRad-ICH is an AI-powered, computer-aided triage and notification application developed by CuraCloud. It is designed to detect intracranial hemorrhage (ICH) on adult noncontrast head CT scans, helping to prioritize the clinical assessment of these cases. The software analyzes cases using deep-learning algorithms and outputs its findings to a PACS workstation for worklist prioritization.
CuraRad-ICH has received U.S. Food and Drug Administration (FDA) 510(k) clearance. This clearance indicates that the software is deemed safe and effective for its intended use in aiding the detection of intracranial hemorrhage.
Yes, there are other AI-powered solutions for ICH detection. Examples include Viz ICH Plus software, which offers automated detection, labeling, and volume quantification for segmentable brain structures, and Scaida BrainCT-ICH software, which provides automated analysis of non-contrast head CT scans for ICH.
While CuraRad-ICH is designed to aid in triage, the diagnosis remains entirely with the physician who interprets the scan. The software's core AI engine processes each case in approximately 20 seconds.
The pricing details for CuraRad-ICH are not publicly available and are marked as unknown.

Related Tools

Parkiwatch
Koios Care
Neurology AI
Parkiwatch by Koios Care is a Class IIa Software as a Medical Device (EU MDR 2017/745) for continuous, passive detection and quantitative assessment of kinematic patterns representative of tremor, bradykinesia, and dyskinesia in adults with Parkinson's Disease.
Paid
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.
NeuroAstra
Avinya NeuroTech
Clinical Decision Support & Reference
NeuroAstra is an AI-enabled EEG analysis and reporting software that provides a multimodal clinical EEG web platform with Co-Pilot AI to help neuro care teams detect abnormal trends faster and standardize reporting.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.